Human SREBF1 shRNA in Retroviral Vector
Quick Overview for Human SREBF1 shRNA in Retroviral Vector (ABIN3651083)
Gene
Application
Insert
Vector
Vector Backbone
Promoter
Bacterial Resistance
Expression Type
-
-
Species
- Human
-
Supplier Product No.
- tr309117
-
Supplier
- OriGene
-
Purpose
- Pre-designed Hush-29 shRNAs in viral vectors with proven effectiveness for knock-down of Human SREBF1.
-
Brand
- HuSH-29™
-
Specificity
-
- The HuSH shRNA gene-specific expression cassettes were optimized to include both the termination signal for RNA Pol III and GC content targeted at 50 % to further improve the quality of the gene-specific shRNA expression vectors.
- One of the four constructs at minimum are guaranteed to produce 70 % or more gene expression knock-down provided a minimum transfection efficiency of 80 % is achieved.
-
Characteristics
-
- The shRNA gene-specific expression cassettes are prepared using synthetic oligonucleotides.
- These oligonucleotide sequences were computer designed for optimal suppression of gene expression and minimal off-target effects.
- All shRNA sequences are verified through DNA sequencing analysis.
-
Components
-
- Gene-specific shRNA expression pRS vectors, 5 ug plasmid DNA per vial.
- Four unique constructs per gene.
- HuSH 29-mer NonEffective Scrambled pRS 5 ug plasmid DNA.
-
Selectable Marker
- Puromycin
-
-
-
-
Application Notes
-
- Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection.
- To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples..
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- The dried plasmids can be stored at 4°C. However, once reconstituted with dH2O, the plasmids must be stored at -20°C.
-
-
-
: "Activation of androgen receptor, lipogenesis, and oxidative stress converged by SREBP-1 is responsible for regulating growth and progression of prostate cancer cells." in: Molecular cancer research : MCR, Vol. 10, Issue 1, pp. 133-42, (2012) (PubMed).
: "Androgen receptor survival signaling is blocked by anti-beta2-microglobulin monoclonal antibody via a MAPK/lipogenic pathway in human prostate cancer cells." in: The Journal of biological chemistry, Vol. 285, Issue 11, pp. 7947-56, (2010) (PubMed).
-
-
- SREBF1 (Sterol Regulatory Element Binding Transcription Factor 1 (SREBF1))
-
Alternative Name
- SREBF1
Target
-